''Infections - Viral Infections Drug Pipeline Report'' - Detailed Independent Intelligence on Product Pipeline
Posted on: Friday, 31 August 2007, 09:09 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c67145) has announced the addition of Infections - Viral Infections Drug Pipeline Report to their offering.
"Infections - Viral Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of viral infections drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Report Topics:
- Viral Infections Pipeline Overview
- Company Overview - Pipeline Projects
- Full Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c67145
Source: Life Science Analytics
Source: Business Wire
Related Articles
- A Weekly R&D Pipeline News Analysis - A Technology Edition Providing a Valuable Competitive Intelligence Tool for the Biopharmaceutical Industry
- New Mike Hurst Article Available at Expert411.Com Examines How to Prevent Infection From IV Therapy Complications, Including Topic Overview, Nursing Perspective & Baxa Corporation's PadLock(R) Solution
- Quick-Med Technologies, Inc. Signs Joint Development Agreement With a Leading Provider of Health Care Products
- American Specialty Health Selected to Provide Complementary Health Care Products and Services for Aetna's Discount Program
- Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
- Zimbabwe Fails to Meet WHO Target of Providing Drugs to AIDS Patients
- South Korea to Push for Local Production of Bird Flu Drug
- Omnify 3.0 Accelerates Product Development and Provides Greater Collaboration for Manufacturers
- Behavioral Therapies for Drug Abuse
- Unocal Provides Update on Earnings, Production, Operating Activities
User Comments (0)
RSS Feeds